IRadimed Corporation
IRMD
$92.50
$1.291.41%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -9.63% | 24.13% | 25.17% | 10.44% | 17.81% |
| Total Depreciation and Amortization | 97.12% | 134.54% | 95.03% | 94.18% | 4.47% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -26.54% | -33.33% | 606.28% | 8.02% | 199.24% |
| Change in Net Operating Assets | -139.45% | 194.84% | -1,952.46% | -92.87% | -64.23% |
| Cash from Operations | -23.33% | 93.15% | -1.07% | -23.36% | 16.70% |
| Capital Expenditure | 92.98% | 89.10% | 89.46% | 70.14% | -132.39% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -37.23% | 70.00% | 54.20% | 37.52% | -38.75% |
| Cash from Investing | 84.31% | 88.03% | 86.38% | 68.50% | -122.40% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -143.75% | 56.90% | -327.66% | -66.29% | -50.23% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -18.32% | -18.22% | -350.01% | -13.79% | -13.76% |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -23.66% | -14.40% | -349.78% | -14.28% | -15.14% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1.54% | 374.04% | -1,146.03% | 10.81% | -21.81% |